Analysis of serum levels of cytokines, chemokines, growth factors, and monoamine neurotransmitters in patients with tick-borne encephalitis: Identification of novel inflammatory markers with implications for pathogenesis
Tick‐borne encephalitis (TBE) is a leading human neuroinfection in Europe and northeastern Asia. However, the pathophysiology of TBE is not understood completely. This study sought to determine the specific serum mediators that are associated with acute TBE. The levels of 30 cytokines, chemokines, a...
Saved in:
Published in | Journal of medical virology Vol. 87; no. 5; pp. 885 - 892 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.05.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Tick‐borne encephalitis (TBE) is a leading human neuroinfection in Europe and northeastern Asia. However, the pathophysiology of TBE is not understood completely. This study sought to determine the specific serum mediators that are associated with acute TBE. The levels of 30 cytokines, chemokines, and growth factors were measured in serum samples from 87 patients with clinically and serologically confirmed acute TBE and from 32 control subjects using the Cytokine Human Magnetic 30‐Plex Panel for the Luminex platform. Serum levels of the monoamine neurotransmitters serotonin, dopamine, and noradrenaline were measured via enzyme‐linked immunosorbent assay. TBE virus infection elicited increased levels of the pro‐inflammatory cytokines interleukin (IL)‐6, IL‐8, and IL‐12. TBE patients had higher IL‐12:IL‐4 and IL‐12:IL‐10 ratios than control patients, reflecting the global pro‐inflammatory cytokine balance. Serum levels of the monoamine neurotransmitters serotonin, dopamine, and noradrenaline were significantly lower in TBE patients than in the control group. Most interestingly, increased levels of hepatocyte growth factor and vascular endothelial growth factor were observed in TBE patients; these proteins may be novel and mechanistically important inflammatory biomarkers of TBE. J. Med. Virol. 87:885–892, 2015. © 2015 Wiley Periodicals, Inc. |
---|---|
Bibliography: | Czech Science Foundation - No. P502/11/2116; No. GA14-29256S MEYS of the Czech Republic under the NPU I program - No. LO1218 istex:63CBDC81607ABF2EDDCBD19C4877987172B688B9 ArticleID:JMV24140 ark:/67375/WNG-3B4KH784-X ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0146-6615 1096-9071 1096-9071 |
DOI: | 10.1002/jmv.24140 |